Zenas BioPharma Files 8-K on Operations and Financials
Ticker: ZBIO · Form: 8-K · Filed: May 15, 2025 · CIK: 1953926
Sentiment: neutral
Topics: 8-K, financial-condition, operations
TL;DR
Zenas BioPharma dropped an 8-K on May 15th about their financials. Check it out.
AI Summary
On May 15, 2025, Zenas BioPharma, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were provided in the excerpt.
Why It Matters
This 8-K filing indicates Zenas BioPharma is providing updates on its financial health and operational status to the SEC, which is important for investors to monitor.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report for operational and financial updates, with no immediate indication of significant risk or negative events.
Key Players & Entities
- Zenas BioPharma, Inc. (company) — Registrant
- May 15, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-42270 (identifier) — Commission File Number
- 852 Winter Street, Suite 250 (address) — Principal executive offices
- Waltham, MA (location) — City, State of principal executive offices
- 02451 (zip_code) — ZIP code of principal executive offices
- 857-271-2954 (phone_number) — Registrant's telephone number
FAQ
What specific financial results are being reported by Zenas BioPharma?
The filing indicates that the report concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but the specific financial figures are not detailed in the provided excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 15, 2025.
What is Zenas BioPharma's state of incorporation?
Zenas BioPharma, Inc. is incorporated in Delaware.
What is the principal executive office address for Zenas BioPharma?
The principal executive office address is 852 Winter Street, Suite 250, Waltham, MA 02451.
What is the Commission File Number for Zenas BioPharma?
The Commission File Number for Zenas BioPharma is 001-42270.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding Zenas BioPharma, Inc. (ZBIO).